Principal Financial Group Inc. Has $114,000 Stake in agilon health, inc. (NYSE:AGL)

Principal Financial Group Inc. reduced its stake in agilon health, inc. (NYSE:AGL) by 30.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,894 shares of the company’s stock after selling 12,781 shares during the period. Principal Financial Group Inc.’s holdings in agilon health were worth $114,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Virtu Financial LLC acquired a new position in agilon health during the 3rd quarter worth about $120,000. Geode Capital Management LLC raised its position in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares during the last quarter. Barclays PLC lifted its stake in shares of agilon health by 21.2% in the third quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after acquiring an additional 214,830 shares during the period. XTX Topco Ltd boosted its holdings in agilon health by 271.1% in the third quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock valued at $471,000 after acquiring an additional 87,481 shares during the last quarter. Finally, State Street Corp increased its position in agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the period.

agilon health Stock Up 4.9 %

Shares of AGL stock opened at $2.16 on Wednesday. The company has a 50 day simple moving average of $2.08 and a two-hundred day simple moving average of $3.82. The stock has a market cap of $889.96 million, a P/E ratio of -2.30 and a beta of 0.53. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $9.30. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the prior year, the firm earned ($0.06) EPS. On average, research analysts expect that agilon health, inc. will post -0.52 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on AGL shares. Evercore ISI dropped their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Stifel Nicolaus decreased their target price on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research note on Tuesday, November 12th. Royal Bank of Canada reissued an “outperform” rating and issued a $3.00 price target on shares of agilon health in a research note on Tuesday, November 19th. Finally, TD Cowen reduced their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $3.95.

Insiders Place Their Bets

In other news, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Diana Mckenzie purchased 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The stock was acquired at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the acquisition, the director now owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 90,000 shares of company stock worth $198,100 in the last 90 days. 3.20% of the stock is currently owned by corporate insiders.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.